Vynleads (VYND) Revenue (2020 - 2022)
Vynleads (VYND) reported Revenue of $49.0 for Q2 2022, down 75.86% year-over-year from $203.0 in Q2 2021, and down 75.86% on a QoQ basis from $203.0 in Q2 2021.
Vynleads (VYND) has 3 years of Revenue data on file, last reported at $49.0 in Q2 2022.
- Quarterly Revenue fell 75.86% year-over-year to $49.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $49.0 (changed N/A YoY) and the FY2022 annual result came in at $49.0, down 89.88% from the prior year.
- Revenue fell to $49.0 in Q2 2022 per VYND's latest filing, from $203.0 in the prior quarter.
- Across five years, Revenue topped out at $23388.0 in Q1 2020 and bottomed at $49.0 in Q2 2022.
- The 3-year median for Revenue is $770.0 (2020), against an average of $6970.7.
- The widest annual swing landed in 2021, when Revenue plunged 98.8%; it then plunged 75.86% in 2022.
- Tracing VYND's Revenue over 3 years: stood at $770.0 in 2020, then slumped by 73.64% to $203.0 in 2021, then sank by 75.86% to $49.0 in 2022.
- Per Business Quant, the three latest VYND Revenue figures stand at $49.0 (Q2 2022), $203.0 (Q2 2021), and $281.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 835.95 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.61 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 354.64 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 182.31 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 145.37 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 313.87 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 150.84 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 603.85 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 309.88 Mn |
| 10 | Vynleads | - | - | -2,028.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 49.00 |
| Jun 30, 2021 | 203.00 |
| Mar 31, 2021 | 281.00 |
| Dec 31, 2020 | 770.00 |
| Sep 30, 2020 | 8,379.00 |
| Jun 30, 2020 | 15,725.00 |
| Mar 31, 2020 | 23,388.00 |